drugset / Trial / NCT00112021
A Study to Examine the Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a study to examine the effect of pramlintide on body weight and its safety and tolerability in obese subjects.
Timeline
- Start
- 2005-05
- Primary completion
- 2005-11
- Completion
- 2005-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pramlintide | Peptide | 120 ug | Subcutaneous |
| Subject | Pramlintide | Peptide | 240 ug | Subcutaneous |
| Subject | Pramlintide | Peptide | 360 ug | Subcutaneous |